Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 292,735	$ 279,058
Accounts receivable, net of reserves of $4,182 in 2014 and $3,533 in 2013	160,467	158,038
Inventories	156,007	133,427
Deferred income tax assets	33,258	33,226
Other current assets	60,154	48,957
Total current assets	702,621	652,706
Long-Term Assets:
Property and equipment, net	291,701	281,214
Goodwill	176,537	180,521
Intangible assets, net	59,210	58,844
Other long-term assets, net	60,563	57,231
Total long-term assets	588,011	577,810
TOTAL ASSETS	1,290,632	1,230,516
Current Liabilities:
Accounts payable	58,255	29,941
Accrued liabilities	167,449	148,919
Line of credit	375,000	277,000
Current portion of long-term debt		1,035
Current portion of deferred revenue	29,560	21,458
Total current liabilities	630,264	478,353
Long-Term Liabilities:
Deferred income tax liabilities	27,760	33,948
Long-term debt, net of current portion	350,000	150,359
Long-term deferred revenue, net of current portion	21,549	18,427
Other long-term liabilities	31,588	31,215
Total long-term liabilities	430,897	233,949
Total liabilities	1,061,161	712,302
Commitments and Contingencies (Note 14)
Stockholders' Equity:
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 101,704 and 101,188 shares in 2014 and 2013, respectively	10,170	10,119
Additional paid-in capital	866,213	825,320
Deferred stock units: Outstanding: 123 and 122 units in 2014 and 2013, respectively	5,253	5,110
Retained earnings	1,649,337	1,493,393
Accumulated other comprehensive income	1,990	13,622
Treasury stock, at cost: 53,436 and 49,649 shares in 2014 and 2013, respectively	(2,303,575)	(1,829,378)
Total IDEXX Laboratories, Inc. stockholders' equity	229,388	518,186
Noncontrolling interest	83	28
Total stockholders' equity	229,471	518,214
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,290,632	$ 1,230,516